awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q55556494-233AC378-0967-43E8-BCED-296587ED1035
Q55556494-233AC378-0967-43E8-BCED-296587ED1035
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55556494-233AC378-0967-43E8-BCED-296587ED1035
[Application of Bevacizumab in Non-small Cell Lung Cancer].
P2860
Q55556494-233AC378-0967-43E8-BCED-296587ED1035
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55556494-233AC378-0967-43E8-BCED-296587ED1035
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fdf2c0764957c377062306c4f126e9a7b3466f69
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.